JP2006204290A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006204290A5 JP2006204290A5 JP2005365540A JP2005365540A JP2006204290A5 JP 2006204290 A5 JP2006204290 A5 JP 2006204290A5 JP 2005365540 A JP2005365540 A JP 2005365540A JP 2005365540 A JP2005365540 A JP 2005365540A JP 2006204290 A5 JP2006204290 A5 JP 2006204290A5
- Authority
- JP
- Japan
- Prior art keywords
- steap
- antibody
- fragment
- protein
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/455,486 US6833438B1 (en) | 1999-06-01 | 1999-12-06 | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541031A Division JP4827357B2 (ja) | 1999-12-06 | 2000-12-06 | ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006204290A JP2006204290A (ja) | 2006-08-10 |
| JP2006204290A5 true JP2006204290A5 (enExample) | 2008-01-31 |
Family
ID=23809010
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541031A Expired - Lifetime JP4827357B2 (ja) | 1999-12-06 | 2000-12-06 | ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 |
| JP2005365540A Withdrawn JP2006204290A (ja) | 1999-12-06 | 2005-12-19 | ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 |
| JP2010212334A Pending JP2011062201A (ja) | 1999-12-06 | 2010-09-22 | ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541031A Expired - Lifetime JP4827357B2 (ja) | 1999-12-06 | 2000-12-06 | ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010212334A Pending JP2011062201A (ja) | 1999-12-06 | 2010-09-22 | ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP1244705B1 (enExample) |
| JP (3) | JP4827357B2 (enExample) |
| AT (1) | ATE456578T1 (enExample) |
| AU (2) | AU775366B2 (enExample) |
| CA (1) | CA2395053C (enExample) |
| CY (1) | CY1111034T1 (enExample) |
| DE (1) | DE60043784D1 (enExample) |
| DK (1) | DK1244705T3 (enExample) |
| ES (1) | ES2340249T3 (enExample) |
| IL (3) | IL150018A0 (enExample) |
| PT (1) | PT1244705E (enExample) |
| WO (1) | WO2001040276A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| EP2080802B1 (en) | 1998-06-01 | 2017-03-29 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| US7611892B2 (en) | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US7189565B2 (en) | 2001-03-23 | 2007-03-13 | Fahri Saatcioglu | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| WO2005114216A2 (en) * | 2005-02-22 | 2005-12-01 | Biomedisinsk Innovasjon As | Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| AU2001270118A1 (en) * | 2000-08-24 | 2002-03-04 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| EP2287186B1 (en) * | 2001-09-06 | 2014-12-31 | Agensys, Inc. | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| AU2003223469A1 (en) * | 2002-04-05 | 2003-10-27 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| EP2181595A1 (en) * | 2002-08-16 | 2010-05-05 | Yeda Research And Development Company Ltd. | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| JP5840351B2 (ja) | 2002-09-06 | 2016-01-06 | アジェンシス，インコーポレイテッド | 癌の処置および検出において有用な９８ｐ４ｂ６と称される、核酸および対応タンパク質 |
| JP2006522122A (ja) * | 2003-03-05 | 2006-09-28 | インネクサス バイオテクノロジー インコーポレイテッド | 膜貫通抗体誘導型のアポトーシス阻害 |
| CN107213469A (zh) * | 2003-11-06 | 2017-09-29 | 西雅图基因公司 | 能够与配体偶联的单甲基缬氨酸化合物 |
| CA2563735C (en) | 2004-04-22 | 2020-07-14 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| JP4191189B2 (ja) | 2005-12-08 | 2008-12-03 | 康生 梅津 | がん関連遺伝子活性化能を有するペプチド |
| WO2008021290A2 (en) | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| EP2061814B1 (en) | 2006-10-27 | 2012-06-06 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
| JP5394246B2 (ja) * | 2007-03-30 | 2014-01-22 | ジェネンテック， インコーポレイテッド | 抗体及びイムノコンジュゲートとこれらの使用方法 |
| CL2008002083A1 (es) | 2007-07-16 | 2008-11-21 | Genentech Inc | Anticuerpo humanizado anti-cd79b/igbeta/b29; inmunoconjugado; metodo in vitro para determinar presencia de cd79b, inhibir crecimiento de celula con cd79b, o para detectara celula b; metodo para elaborar dicho anticyerpo humanizado; acido nucleico; celula huesped; composicion; metodo de elaboracion de inmunoconjugado; uso medico |
| NZ583367A (en) | 2007-07-16 | 2012-10-26 | Genentech Inc | Anti-cd79b antibodies and immunoconjugates and methods of use |
| WO2009046739A1 (en) * | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating prostate cancer (pca) |
| ES2643239T3 (es) | 2008-01-31 | 2017-11-21 | Genentech, Inc. | Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso |
| WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| WO2014165818A2 (en) | 2013-04-05 | 2014-10-09 | T Cell Therapeutics, Inc. | Compositions and methods for preventing and treating prostate cancer |
| DK3262071T3 (da) | 2014-09-23 | 2020-06-15 | Hoffmann La Roche | Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater |
| EP4183806A3 (en) | 2014-11-12 | 2023-08-02 | Seagen Inc. | Glycan-interacting compounds and methods of use |
| US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| CN108463248B (zh) | 2015-11-12 | 2022-10-21 | 西雅图基因公司 | 聚糖相互作用化合物及使用方法 |
| WO2018058001A1 (en) * | 2016-09-23 | 2018-03-29 | Regeneron Pharmaceuticals, Inc. | Anti-steap2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind steap2 and cd3, and uses thereof |
| WO2018094143A1 (en) | 2016-11-17 | 2018-05-24 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| WO2018160909A1 (en) | 2017-03-03 | 2018-09-07 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| AU2018247767B2 (en) | 2017-04-03 | 2025-01-30 | F. Hoffmann-La Roche Ag | Antibodies binding to STEAP-1 |
| WO2019125184A1 (en) | 2017-12-19 | 2019-06-27 | Auckland Uniservices Limited | Use of biomarker in cancer therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489525A (en) * | 1992-10-08 | 1996-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies to prostate cells |
| US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
| WO1998018489A1 (en) * | 1996-10-30 | 1998-05-07 | The Uab Research Foundation | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies |
| US6048970A (en) * | 1998-05-22 | 2000-04-11 | Incyte Pharmaceuticals, Inc. | Prostate growth-associated membrane proteins |
| EP2080802B1 (en) * | 1998-06-01 | 2017-03-29 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| JP2002532083A (ja) * | 1998-12-17 | 2002-10-02 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ４７個のヒト分泌タンパク質 |
| US20020015950A1 (en) * | 1999-07-07 | 2002-02-07 | Karen Anne Jones | Atherosclerosis-associated genes |
| CA2382015A1 (en) * | 1999-08-17 | 2001-02-22 | Incyte Genomics, Inc. | Membrane associated proteins |
-
2000
- 2000-12-06 EP EP00983938A patent/EP1244705B1/en not_active Expired - Lifetime
- 2000-12-06 JP JP2001541031A patent/JP4827357B2/ja not_active Expired - Lifetime
- 2000-12-06 DK DK00983938.2T patent/DK1244705T3/da active
- 2000-12-06 CA CA2395053A patent/CA2395053C/en not_active Expired - Lifetime
- 2000-12-06 AT AT00983938T patent/ATE456578T1/de active
- 2000-12-06 DE DE60043784T patent/DE60043784D1/de not_active Expired - Lifetime
- 2000-12-06 AU AU20629/01A patent/AU775366B2/en not_active Expired
- 2000-12-06 ES ES00983938T patent/ES2340249T3/es not_active Expired - Lifetime
- 2000-12-06 WO PCT/US2000/033040 patent/WO2001040276A2/en not_active Ceased
- 2000-12-06 EP EP05014435A patent/EP1642909A3/en not_active Withdrawn
- 2000-12-06 IL IL15001800A patent/IL150018A0/xx unknown
- 2000-12-06 PT PT00983938T patent/PT1244705E/pt unknown
-
2002
- 2002-06-04 IL IL150018A patent/IL150018A/en active IP Right Grant
-
2004
- 2004-10-29 AU AU2004224964A patent/AU2004224964B2/en not_active Expired
-
2005
- 2005-12-19 JP JP2005365540A patent/JP2006204290A/ja not_active Withdrawn
-
2009
- 2009-06-10 IL IL199275A patent/IL199275A0/en active IP Right Grant
-
2010
- 2010-04-26 CY CY20101100373T patent/CY1111034T1/el unknown
- 2010-09-22 JP JP2010212334A patent/JP2011062201A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006204290A5 (enExample) | ||
| JP2010537671A5 (enExample) | ||
| JP2008541711A5 (enExample) | ||
| JP2011502517A5 (enExample) | ||
| AU2011360938B2 (en) | Novel modulators and methods of use | |
| AU2026200768A1 (en) | Tem8 antibodies and their use | |
| RU2007147596A (ru) | Моноклональные антитела и одноцепочечные фрагменты антител против клеточно-поверхностного специфического для простаты мембранного антигена | |
| JP2015172045A5 (enExample) | ||
| JP2008538289A5 (enExample) | ||
| RU2006105339A (ru) | Rg1 антитела и их применение | |
| Mayer et al. | Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT) | |
| JP2009197002A5 (enExample) | ||
| CA2395053A1 (en) | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof | |
| JP2012012402A5 (enExample) | ||
| JP2014527398A5 (enExample) | ||
| JP2013513380A5 (enExample) | ||
| JP2011501946A5 (enExample) | ||
| JP2015510761A5 (enExample) | ||
| CA2827637A1 (en) | Novel modulators and methods of use | |
| JP2011518773A5 (enExample) | ||
| JP2005528914A5 (enExample) | ||
| JP2013517464A (ja) | 皮膚ｔ細胞リンパ腫の診断及び処置のための方法 | |
| JP2012505659A5 (enExample) | ||
| JP2007525183A5 (enExample) | ||
| RU2007140311A (ru) | Антитела и родственные молекулы, связываюшиеся с белками 161p2f10b |